249 related articles for article (PubMed ID: 37394299)
1. Decoding the microbiome: advances in genetic manipulation for gut bacteria.
Chen Z; Jin W; Hoover A; Chao Y; Ma Y
Trends Microbiol; 2023 Nov; 31(11):1143-1161. PubMed ID: 37394299
[TBL] [Abstract][Full Text] [Related]
2. Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome.
Nath A; Bhattacharjee R; Nandi A; Sinha A; Kar S; Manoharan N; Mitra S; Mojumdar A; Panda PK; Patro S; Dutt A; Ahuja R; Verma SK; Suar M
Biomed Pharmacother; 2022 Jul; 151():113122. PubMed ID: 35594718
[TBL] [Abstract][Full Text] [Related]
3. Genetic Engineering of Resident Bacteria in the Gut Microbiome.
Arnold J; Glazier J; Mimee M
J Bacteriol; 2023 Jul; 205(7):e0012723. PubMed ID: 37382533
[TBL] [Abstract][Full Text] [Related]
4. Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome.
Jin WB; Li TT; Huo D; Qu S; Li XV; Arifuzzaman M; Lima SF; Shi HQ; Wang A; Putzel GG; Longman RS; Artis D; Guo CJ
Cell; 2022 Feb; 185(3):547-562.e22. PubMed ID: 35051369
[TBL] [Abstract][Full Text] [Related]
5. Editing the microbiome the CRISPR way.
Ramachandran G; Bikard D
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180103. PubMed ID: 30905295
[TBL] [Abstract][Full Text] [Related]
6. Universal gut microbial relationships in the gut microbiome of wild baboons.
Roche KE; Bjork JR; Dasari MR; Grieneisen L; Jansen D; Gould TJ; Gesquiere LR; Barreiro LB; Alberts SC; Blekhman R; Gilbert JA; Tung J; Mukherjee S; Archie EA
Elife; 2023 May; 12():. PubMed ID: 37158607
[TBL] [Abstract][Full Text] [Related]
7. Identification of Natural CRISPR Systems and Targets in the Human Microbiome.
Münch PC; Franzosa EA; Stecher B; McHardy AC; Huttenhower C
Cell Host Microbe; 2021 Jan; 29(1):94-106.e4. PubMed ID: 33217332
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas systems in oral microbiome: From immune defense to physiological regulation.
Gong T; Zeng J; Tang B; Zhou X; Li Y
Mol Oral Microbiol; 2020 Apr; 35(2):41-48. PubMed ID: 31995666
[TBL] [Abstract][Full Text] [Related]
9. CRISPR technologies for bacterial systems: Current achievements and future directions.
Choi KR; Lee SY
Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
[TBL] [Abstract][Full Text] [Related]
10. Immune Gene Expression Covaries with Gut Microbiome Composition in Stickleback.
Fuess LE; den Haan S; Ling F; Weber JN; Steinel NC; Bolnick DI
mBio; 2021 May; 12(3):. PubMed ID: 33947750
[TBL] [Abstract][Full Text] [Related]
11. Toward a genetic tool development pipeline for host-associated bacteria.
Waller MC; Bober JR; Nair NU; Beisel CL
Curr Opin Microbiol; 2017 Aug; 38():156-164. PubMed ID: 28624690
[TBL] [Abstract][Full Text] [Related]
12. Advances in synthetic biology toolboxes paving the way for mechanistic understanding and strain engineering of gut commensal Bacteroides spp. and Clostridium spp.
Tan Y; Liang J; Lai M; Wan S; Luo X; Li F
Biotechnol Adv; 2023 Dec; 69():108272. PubMed ID: 37844770
[TBL] [Abstract][Full Text] [Related]
13. Artificial intelligence and synthetic biology approaches for human gut microbiome.
Kumar P; Sinha R; Shukla P
Crit Rev Food Sci Nutr; 2022; 62(8):2103-2121. PubMed ID: 33249867
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
15. Overview of the rules of the microbial engagement in the gut microbiome: a step towards microbiome therapeutics.
Yadav M; Chauhan NS
J Appl Microbiol; 2021 May; 130(5):1425-1441. PubMed ID: 33022786
[TBL] [Abstract][Full Text] [Related]
16. Systems to model the personalized aspects of microbiome health and gut dysbiosis.
Matthewman C; Narin A; Huston H; Hopkins CE
Mol Aspects Med; 2023 Jun; 91():101115. PubMed ID: 36104261
[TBL] [Abstract][Full Text] [Related]
17. Species- and site-specific genome editing in complex bacterial communities.
Rubin BE; Diamond S; Cress BF; Crits-Christoph A; Lou YC; Borges AL; Shivram H; He C; Xu M; Zhou Z; Smith SJ; Rovinsky R; Smock DCJ; Tang K; Owens TK; Krishnappa N; Sachdeva R; Barrangou R; Deutschbauer AM; Banfield JF; Doudna JA
Nat Microbiol; 2022 Jan; 7(1):34-47. PubMed ID: 34873292
[TBL] [Abstract][Full Text] [Related]
18. Engineering commensal bacteria to rewire host-microbiome interactions.
Hwang IY; Chang MW
Curr Opin Biotechnol; 2020 Apr; 62():116-122. PubMed ID: 31654857
[TBL] [Abstract][Full Text] [Related]
19. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
20. The impact of the gut microbiome on toxigenic bacteria.
Koosha RZ; Fazel P; Sedighian H; Behzadi E; Ch MH; Imani Fooladi AA
Microb Pathog; 2021 Nov; 160():105188. PubMed ID: 34530074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
